Survey of psychiatric symptoms among inpatients with COVID-19 using the Diagnosis Procedure Combination data and medical records in Japan.

Autor:	Nakao T; Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Murayama K; Department of Psychiatry and Neurology, Kyushu University Hospital, Fukuoka, Japan., Fukuda H; Kyushu University Graduate School of Medicine, Department of Healthcare Management and Administration, Affiliated Cohort Center, Fukuoka, Japan., Eto N; Department of Psychiatry, Fukuoka University School of Medicine, Fukuoka, Japan., Fujita K; Kitakyushu Municipal Mental Health Welfare Center, Kitakyushu, Japan., Igata R; Department of Psychiatry, Faculty of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan., Ishikawa K; Department of Neuropsychiatry, Kyushu Medical Center, Fukuoka, Japan., Isomura S; Department of Psychiatry, Kokura Medical Center, Kitakyushu, Japan., Kawaguchi T; Fukuoka City Mental Health Welfare Center, Fukuoaka, Japan., Maeda M; Kyushu University Graduate School of Medicine, Department of Healthcare Management and Administration, Fukuoka, Japan., Mitsuyasu H; Iizuka Hospital Liaison Psychiatry, Iizuka, Japan., Murata F; Kyushu University Graduate School of Medicine, Department of Healthcare Management and Administration, Affiliated Cohort Center, Fukuoka, Japan., Nakamura T; Department of Neuropsychiatry, Kurume University School of Medicine, Kurume, Japan., Nishihara T; Department of Psychosomatic Medicine, Fukuoka Higashi Medical Center, Koga, Japan., Ohashi A; Department of Psychiatry and Neurology, Kyushu University Hospital, Fukuoka, Japan., Sato M; Research Institute for Higher Brain Diseases, Kurume University, Kurume, Japan., Yoshida Y; Department of Psychiatry, Kitakyushu Municipal Medical Center, Kitakyushu, Japan., Kawasaki H; Department of Psychiatry, Fukuoka University School of Medicine, Fukuoka, Japan., Ozone M; Department of Neuropsychiatry, Kurume University School of Medicine, Kurume, Japan., Yoshimura R; Department of Psychiatry, Faculty of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan., Tatebayashi H; Fukuoka Prefectural Mental Health Services Center, Kasuga, Japan.
Jazyk:	angličtina
Zdroj:	Brain, behavior, & immunity - health [Brain Behav Immun Health] 2023 May; Vol. 29, pp. 100615. Date of Electronic Publication: 2023 Mar 24.
DOI:	10.1016/j.bbih.2023.100615
Abstrakt:	Physical symptoms such as fatigue and muscle weakness, and psychiatric symptoms like depression and anxiety are considered as complications and sequelae of COVID-19. This epidemiological study investigated the actual status of psychiatric symptoms and disorders caused by COVID-19, from four major university hospitals and five general hospitals in Fukuoka Prefecture, Japan, having a population of 5 million. We conducted a survey of psychiatric disorders associated with COVID-19 using Diagnosis Procedure Combination (DPC) data and the psychiatric records of the hospitals. In the study period from January 2019 to September 2021, 2743 COVID-19 admissions were determined from DPC data across the nine sites. These subjects had significantly more anxiety, depression, and insomnia, and were receiving higher rates of various psychotropic medications than controls influenza and respiratory infections. A review of psychiatric records revealed that the frequency of organic mental illness with insomnia and confusion was proportional to the severity of COVID-19 infection and that anxiety symptoms appeared independent of infection severity. These results indicate that COVID-19 is more likely to produce psychiatric symptoms such as anxiety and insomnia than conventional infections. Competing Interests: None. (© 2023 The Authors.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu